SA PRO
Free Account
Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
OverviewIntelligenceChartsNews
Debt Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR+10.0%
5Y CAGR-15.0%
Studio
Year-over-Year Change

Year-over-year debt growth rate

3Y CAGR
+10.0%/yr
vs -58.7%/yr prior
5Y CAGR
-15.0%/yr
Recent acceleration
Acceleration
+68.7pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 20250.01%
Q3 20250.01%
Q2 20250.01%
Q1 20250.01%
Q4 20240.01%
Q3 20240.01%
Q2 20240.01%
Q1 20240.01%
Q4 20230.01%
Q3 20230.01%
Q2 20230.01%
Q1 20230.01%
Q4 20220.01%
Q3 20220.01%
Q2 20220.01%
Q1 20220.03%
Q4 20210.04%
Q3 20210.04%
Q2 20210.03%
Q1 20210.04%
Q4 20200.03%
Q3 202021.61%
Q2 2020209.83%
Q1 20200.18%
Q4 20190.17%
Q3 20190.20%
Q2 20190.20%
Q1 20190.20%
Q4 20180.18%
Q3 20180.18%
Q2 20180.18%
Q1 20180.17%
Q4 20170.16%
Q3 20170.16%
Q2 2017-0.91%
Q1 201747.07%
Q4 201625.87%
Q3 20165.73%
Q2 2016-0.20%
Q1 2016-3.54%

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance